These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 38078929)

  • 1. Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics.
    Watanabe H; Nagano N; Tsuji Y; Noto N; Ayusawa M; Morioka I
    Eur J Clin Pharmacol; 2024 Feb; 80(2):203-221. PubMed ID: 38078929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal clinical pharmacology.
    Allegaert K; van de Velde M; van den Anker J
    Paediatr Anaesth; 2014 Jan; 24(1):30-8. PubMed ID: 23617305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care.
    Mizuno T; Dong M; Taylor ZL; Ramsey LB; Vinks AA
    Br J Clin Pharmacol; 2022 Feb; 88(4):1418-1426. PubMed ID: 32529759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.
    Haas DM
    Obstet Gynecol Surv; 2013 Sep; 68(9):650-4. PubMed ID: 25102121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients.
    Constance JE; Campbell SC; Somani AA; Yellepeddi V; Owens KH; Sherwin CMT
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):715-724. PubMed ID: 28490206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel models for the prediction of drug-gene interactions.
    Türk D; Fuhr LM; Marok FZ; Rüdesheim S; Kühn A; Selzer D; Schwab M; Lehr T
    Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1293-1310. PubMed ID: 34727800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics.
    Quinney SK; Bies RR; Grannis SJ; Bartlett CW; Mendonca E; Rogerson CM; Backes CH; Shah DK; Tillman EM; Costantine MM; Aruldhas BW; Allam R; Grant A; Abbasi MY; Kandasamy M; Zang Y; Wang L; Shendre A; Li L
    Pharmacotherapy; 2023 May; 43(5):391-402. PubMed ID: 36625779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
    Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
    Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
    van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored tools to improve pharmacotherapy in infants.
    Allegaert K
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1069-78. PubMed ID: 24961300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
    Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
    Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics.
    ten Brink MH; Zwaveling J; Swen JJ; Bredius RG; Lankester AC; Guchelaar HJ
    Drug Discov Today; 2014 Oct; 19(10):1572-86. PubMed ID: 24747172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L; Zhu HJ
    Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.